a couple of weeks ago, some of my constituents who are currently serving in Iraq with the 419th Transportation Company learned that their deployment would be extended. These Army Reservists and their unit have already served with great distinction since March of 2003. Their families and loved ones are understandably concerned that these soldiers will not return home this week, as was originally planned, but instead will remain in Iraq. The continued turmoil in Iraq obviously calls on greater sacrifices from members of the Armed Forces, but what is of particular concern is that these soldiers may not be adequately equipped for their mission. Though all members of the 419th have body armor, it has been reported to me that none of their vehicles have been armored. Given that this unit may travel along dangerous and challenging routes in southern and central Iraq, armored plating on all vehicles is not only common sense but it is imperative. Congress has provided many defense resources via the appropriations process, as well it should; and it was my understanding that this funding was to ensure that all soldiers have body armor and armored vehicles. If not, I would hope that the Department of Defense would be quick to ask for additional support from the Congress, as I am certain that providing the best possible tools for soldiers in theater is of paramount priority for many in Congress, like myself.
Jim Matheson: “a couple of weeks ago, some of my constituents who are currently serving in Iraq with the 419th Transportation Company…”
Editor's note · Context
Addressing concerns about the deployment and equipment of the 419th Transportation Company serving in Iraq.
Share
More from Jim Matheson
I think this year we have an opportunity to really get something done, and I think we should all embrace that opportunity to try to work together.
I am very pleased to stand up and offer this bipartisan amendment today, offered by myself and also the gentleman from New Mexico (Mr. Pearce). The amendment addresses an interesting problem, and that is, over history, at times, the…
The bill before us today has two main components. We talk about the drug compounding issue and also the issue of the drug supply chain, how we can track medications through the pharmaceutical supply chain to make sure that the materials…
If the United States leads in that opportunity and develops that technology here, I think that that may have the impact globally over time.





